Featured Press Releases

Bracco Diagnostics Inc. reaches one million injections milestone with its MRI agent, VUEWAY® (gadopiclenol)

Bracco Diagnostics Inc. reaches one million injections milestone with its MRI agent, VUEWAY® (gadopiclenol)

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

  • 18 Jul 2024

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced the launch of a new sprinkle formulation of...

Rehabtronics Selected by Praxis Spinal Cord Institute to Launch Prelivia Pilot

Rehabtronics Selected by Praxis Spinal Cord Institute to Launch Prelivia Pilot

Health Canada has granted Celltrion approval for Eydenzelt®, a biosimilar referencing Eylea® (aflibercept 2mg).

Health Canada has granted Celltrion approval for Eydenzelt®, a biosimilar referencing Eylea® (aflibercept 2mg).

Element Science Receives FDA Approval for the Revolutionary Jewel® Patch Wearable Cardioverter Defibrillator

Element Science Receives FDA Approval for the Revolutionary Jewel® Patch Wearable Cardioverter Defibrillator

ProductLife Group Appoints Dr. James Burt as CEO

ProductLife Group Appoints Dr. James Burt as CEO

Beauty Crush Skincare Introduces a New Standard in Regenerative Biotech Skincare

Beauty Crush Skincare Introduces a New Standard in Regenerative Biotech Skincare

  • Beauty Crush Skincare
  • 04 Jun 2026
Brain Navi’s KrystoLens Receives TFDA Certification and Is Set to Enter the Taiwan Market

Brain Navi’s KrystoLens Receives TFDA Certification and Is Set to Enter the Taiwan Market

  • Brain Navi Biotechnology
  • 04 Jun 2026
SK bioscience Improves Vaccine Access by Securing Its First UNICEF Procurement Contract

SK bioscience Improves Vaccine Access by Securing Its First UNICEF Procurement Contract

  • SK bioscience
  • 03 Jun 2026
ChromaDex Renames Its External Research Program to the Niagen Research Program, Strengthening Niagen Bioscience

ChromaDex Renames Its External Research Program to the Niagen Research Program, Strengthening Niagen Bioscience's Position as the Global Leader in NAD+ Science

  • Niagen Bioscience, Inc
  • 03 Jun 2026
AddiVance Offers a Drug-Free Option for Daily Focus, Attention, and Cognitive Support for Families

AddiVance Offers a Drug-Free Option for Daily Focus, Attention, and Cognitive Support for Families

  • Medella Springs
  • 02 Jun 2026
Seegene Expands Its AMR Testing Portfolio in Europe with the Launch of the Allplex™ MDRO Assay Under IVDR

Seegene Expands Its AMR Testing Portfolio in Europe with the Launch of the Allplex™ MDRO Assay Under IVDR

  • Seegene
  • 02 Jun 2026
The Digital Pharma Advances Conference 2026

Most Popular
June   2026
M T W T F S S
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30          

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.